Addex appoints Dr Bharatt Chowrira CEO
This article was originally published in Scrip
Executive Summary
Addex Pharmaceuticals has appointed Dr Bharatt Chowrira CEO, and dissolved the transition committee led by recently appointed vice-chairman Vincent Lawton, which was set up as an interim measure following the unexpected departure of former CEO Dr Vincent Mutel in June 2011 (scripintelligence.com, 3 June 2011). Dr Chowrira joins Addex from Nektar Therapeutics where he served as senior vice-president and COO, and he was previously executive director of worldwide licensing & external research at Merck & Co.